(R)-3-Nitrobiphenyline
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(R)-2-[1-(3'-Nitrobiphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole
|
|
| Clinical data | |
| MedlinePlus | a682611 |
| Identifiers | |
| PubChem | CID 16757089 |
| ChemSpider | 23288036  |
| ChEMBL | CHEMBL242693 |
| Chemical data | |
| Formula | C17H17N3O3 |
| Molar mass | 311.334 g/mol |
|
|
|
|
| (verify) |
(R)-3-Nitrobiphenyline is a drug which acts as an α2-adrenergic agonist, selective for the α2C subtype, as well as being a weak antagonist at the α2A and α2B subtypes.[1]
References[edit]
- ^ Crassous PA, Cardinaletti C, Carrieri A, Bruni B, Di Vaira M, Gentili F, Ghelfi F, Giannella M, Paris H, Piergentili A, Quaglia W, Schaak S, Vesprini C, Pigini M (August 2007). "Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist". Journal of Medicinal Chemistry 50 (16): 3964–8. doi:10.1021/jm061487a. PMID 17630725.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
